INR Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History

INR Advisory Services’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$91K	Hold	810	–	–	0.01%	20
2018 Q4	$78K	Hold	810	–	–	0.01%	21
2018 Q3	$99K	Hold	810	–	–	0.01%	15
2018 Q2	$89K	Hold	810	–	–	0.01%	18
2018 Q1	$86K	Hold	810	–	–	0.01%	17
2017 Q4	$86K	Hold	810	–	–	0.01%	17
2017 Q3	$90K	Hold	810	–	–	0.01%	16
2017 Q2	$84K	Hold	810	–	–	0.01%	18
2017 Q1	$79K	Hold	810	–	–	0.01%	28
2016 Q4	$72K	Hold	810	–	–	0.01%	27
2016 Q3	$78K	Hold	810	–	–	0.01%	26
2016 Q2	$69K	Hold	810	–	–	0.01%	27
2016 Q1	$70K	Hold	810	–	–	0.01%	25
2015 Q4	$91K	Hold	810	–	–	0.02%	25
2015 Q3	$82K	Hold	810	–	–	0.02%	25
2015 Q2	$100K	Hold	810	–	–	0.02%	25
2015 Q1	$93K	Hold	810	–	–	0.02%	25
2014 Q4	$82K	Hold	810	–	–	0.02%	27
2014 Q3	$74K	Hold	810	–	–	0.02%	34
2014 Q2	$69K	Hold	810	–	–	0.01%	32
2014 Q1	$64K	Hold	810	–	–	0.01%	34
2013 Q4	$61K	Hold	810	–	–	0.01%	33
2013 Q3	$57K	Hold	810	–	–	0.02%	33
2013 Q2	$47K	Buy	+810	New	+$46.8K	0.01%	33

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

DFO

Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Natixis Paris, France $24.8B AUM 35.22% 1-Year Est. Return

INR Advisory Services's IBB Position: Q1 2019 in Review

INR Advisory Services held its iShares Biotechnology ETF (IBB) position steady in Q1 2019 at 810 shares worth $91K. The position accounts for 0.01% of the portfolio, ranked #20.

INR Advisory Services first reported a position in IBB in Q2 2013 and has held it in 24 quarters since. The position peaked at $100K in Q2 2015. 670 funds tracked by Wall St. Rank hold IBB as of Q1 2019.

INR Advisory Services held 810 shares of iShares Biotechnology ETF worth $91K as of Q1 2019.
INR Advisory Services left its iShares Biotechnology ETF share count unchanged in Q1 2019.
iShares Biotechnology ETF made up 0.01% of INR Advisory Services's portfolio in Q1 2019, its #20 holding.
INR Advisory Services first reported a position in iShares Biotechnology ETF in Q2 2013 and has held it in 24 quarters since.
INR Advisory Services's iShares Biotechnology ETF position peaked at $100K in Q2 2015.
670 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2019.

Based on INR Advisory Services's 13F filing for Q1 2019, filed 22 Apr 2019.